ImaBiotech website in English


  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news

HD Biomarker Discovery

Biomarker are the key components for the evaluation of a disease or disease progression.

In order to satisfy efficacy or toxicity investigation, Imabiotech offers new approach of imaging to localize biomarkers of efficacy or toxicity in many different options:

  • Disease state evaluation
  • Disease progression
  • Read-out or companion biomarker for efficacy evaluation
  • Biomarker of drug toxicity

In a single experiment, ImaBiotech evaluates drug distribution with biomarkers using Multimaging platform (Link) which combines different imaging techniques to discover and colocalize drugs and biomarkers together.

Brain Mass Spec Imaging